SCHEMBL7271397

SCHEMBL7271397

CCCCN1CC(C(=O)O)N(C(=O)OCc2ccccc2)C1=O

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ACE P12821 13/20 0.57
FKBP1A P62942 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HTR2C P28335 1/20 0.42
GPBAR1 Q8TDU6 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7271391 1.00 ACE (0.57) ACEFKBP1ANPC1RAB9ASMN1; SMN2
SCHEMBL11285685 0.88 ACE (0.51) ACENPC1RAB9ASMN1; SMN2HTR2C
SCHEMBL11196452 0.88 ACE (0.51) ACENPC1RAB9ASMN1; SMN2HTR2C
SCHEMBL4435031 0.84 ACE (0.61) ACEFKBP1ANPC1RAB9ASMN1; SMN2
SCHEMBL7270216 0.84 ACE (0.61) ACEFKBP1ANPC1RAB9ASMN1; SMN2
SCHEMBL28405346 0.83 ACE (0.48) ACENPC1RAB9ASMN1; SMN2HTR2C
SCHEMBL15134208 0.83 ACE (0.48) ACENPC1RAB9ASMN1; SMN2HTR2C
SCHEMBL7264075 0.83 ACE (0.53) ACENPC1RAB9ASMN1; SMN2HTR2C
SCHEMBL7264101 0.83 ACE (0.53) ACENPC1RAB9ASMN1; SMN2HTR2C
SCHEMBL7263574 0.80 ACE (0.82) ACECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0095163-A2 2-Oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition Tanabe Seiyaku Co., Ltd. (JP) 1983-11-30 EP disclosed
EP-0052696-A1 Novel 2-oxoimidazolidine derivative, a process for preparing same and a pharmaceutical composition containing the 2-oxoimidazolidine derivative Tanabe Seiyaku Co., Ltd. (JP) 1982-06-02 EP disclosed